S
SGMO//CIK 0001001233
SANGAMO THERAPEUTICS, INC
Market Data
$0.50−$0.05 (−9.84%)
SGMO · Last trade
Prev Close
$0.55
Range (29d)
$0.39 – $0.53
Recent Filings
- 8-K161.0 KBSANGAMO THERAPEUTICS, INCDec 30, 4:23 PM ET·0001628280-24-052579
- 8-K13.4 MBSANGAMO THERAPEUTICS, INCJun 5, 5:10 PM ET·0001628280-24-026903
- SC 13G/A13.5 KBSANGAMO THERAPEUTICS, INCJan 24, 1:56 PM ET·0001306550-23-003123
- 8-K177.2 KBSANGAMO THERAPEUTICS, INCSep 22, 5:00 PM ET·0001628280-22-025356
- 8-K173.3 KBSANGAMO THERAPEUTICS, INCAug 9, 4:18 PM ET·0001628280-22-021955
- 8-K174.8 KBSANGAMO THERAPEUTICS, INCNov 19, 7:37 PM ET·0001628280-21-023921
- 8-K184.4 KBSANGAMO THERAPEUTICS, INCMar 17, 5:06 PM ET·0001628280-21-005022
- 8-K111.4 KBSANGAMO THERAPEUTICS, INCFeb 22, 7:18 AM ET·0001193125-18-053085
- 10-Q5.2 MBSANGAMO THERAPEUTICS, INCNov 9, 4:24 PM ET·0001564590-17-023266
- 8-K80.4 KBSANGAMO THERAPEUTICS, INCNov 9, 4:13 PM ET·0001193125-17-338782
Insiders
10- ANDO DALE GVP, Therapeutic Dev. & CMO
- Beers CourtneyDirector
- BIOGEN INC.10% Owner
- BLUFORD PETERV.P., Corporate Development
- Boissel StephaneEVP, Corp. Strategy
- Carey RobertDirector
- CASE CASEY CVice President, Research
- Cleveland Paul BDirector
- Davis Gregory DHead of Research & Technology
- DILLY STEPHEN GEORGEDirector
Tickers
Addresses
business
501 CANAL BLVD.
RICHMOND, CA, 94084
mailing
501 CANAL BLVD.
RICHMOND, CA, 94084
Former Names
- SANGAMO BIOSCIENCES INC2017-01-06